The Administrative Appeals Tribunal's (AAT) first decision on transfer pricing, resulting in an upward adjustment of the gross profit margin of a Swiss pharmacy group's Australian subsidiary is expected to have significant implications for multinational groups operating in Australia. This casenote (Roche Products Pty Ltd) examines the Australian transfer pricing rules and the manner in which expert evidence was evaluated by the AAT to arrive at the above conclusion.